Evidence of chromosomal damage in scleroderma

Pathology. 2022 Feb;54(1):131-133. doi: 10.1016/j.pathol.2021.04.004. Epub 2021 Jun 30.

Authors

K A Patterson¹, J G Walker², P J Roberts-Thomson³, C F Bull⁴, M Fenech⁵

Affiliations

¹ Department of Immunology, Flinders Medical Centre, Bedford Park, SA, Australia. Electronic address: [email protected].
² Rheumatology Unit, Flinders Medical Centre, Bedford Park, SA, Australia.
³ Department of Immunology, Flinders Medical Centre, Bedford Park, SA, Australia.
⁴ CSIRO Health and Nutrition, Adelaide, SA, Australia.
⁵ University of South Australia, Adelaide, SA, Australia.

PMID: 34215445
DOI: 10.1016/j.pathol.2021.04.004

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Autoantibodies / immunology*
Chromosome Aberrations*
DNA Damage
Female
Genomic Instability
Humans
Leukocytes, Mononuclear / immunology
Male
Micronuclei, Chromosome-Defective
Middle Aged
Neoplasms / complications
Neoplasms / genetics*
Scleroderma, Systemic / complications
Scleroderma, Systemic / genetics*

Substances

Autoantibodies